Barrick adopts poison pill

The board of directors of Barrick Gold (ABX-T) has adopted a shareholder-rights plan designed to make the company more difficult to take over.

Barrick will propose the plan — which would remain in effect until 2002 if it is approved — at its annual meeting in May. The plan would allow shareholders to increase their shareholding at a discount to the market price if a person or company announced its intention to acquire 20% or more of the outstanding common shares, unless the bid either complied with the provisions of the plan or the board approved of it.

Under the proposed plan, the emergence of a bidder would trigger an offering allowing shareholders other than the bidder to purchase Barrick shares equivalent to their existing holdings at 50% of the market price. The plan describes a “permitted bid” as one open for at least 60 days and extendable for a further 10 days if at least 50% of the shares in other hands were tendered to the offer by the time the offer expired.

Barrick had earlier announced a normal-course issuer bid for up to 31 million shares, about 10% of its capitalization. If the Toronto Stock Exchange approves, Barrick’s bid would be in effect for a year and the company would buy its shares on the market at prevailing market prices.

Print

Be the first to comment on "Barrick adopts poison pill"

Leave a comment

Your email address will not be published.


*


By continuing to browse you agree to our use of cookies. To learn more, click more information

Dear user, please be aware that we use cookies to help users navigate our website content and to help us understand how we can improve the user experience. If you have ideas for how we can improve our services, we’d love to hear from you. Click here to email us. By continuing to browse you agree to our use of cookies. Please see our Privacy & Cookie Usage Policy to learn more.

Close